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Abstract 
 
Aims: To investigate trajectories of negative symptoms during the first 12 months of 
treatment for first episode psychosis (FEP), their predictors and relationship to social 
recovery.  
 
Method: 1006 participants were followed up for 12 months following acceptance into Early 
Intervention in Psychosis services. Negative symptom trajectories were modelled using latent 
class growth analysis (LCGA) and predictors of trajectories examined using multinomial 
regression. Social recovery trajectories – also modelled using LCGA – of members of each 
negative symptom trajectory were ascertained and the relationship between negative 
symptom and social recovery trajectories examined.       
 
Results: Four negative symptom trajectories were identified: Minimal Decreasing (63.9%), 
Mild Stable (13.5%), High Decreasing (17.1%) and High Stable (5.4%). Male gender and 
family history of non-affective psychosis predicted stably high negative symptoms. Poor 
premorbid adolescent adjustment, family history of non-affective psychosis and baseline 
depression predicted initially high but decreasing negative symptoms. Members of the Mild 
Stable, High Stable and High Decreasing classes were more likely to experience stably low 
functioning than the Minimal Decreasing class.     
 
Conclusions: Distinct negative symptom trajectories are evident in FEP. Only a small 
subgroup present with persistently high levels of negative symptoms. A substantial 
proportion of FEP patients with elevated negative symptoms at baseline will achieve 
remission of these symptoms within 12 months. However, elevated negative symptoms at 
baseline, whether or not they remit, are associated with poor social recovery, suggesting 
targeted interventions for service users with elevated baseline negative symptoms may help 
improve functional outcomes.          
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1. Introduction 
 
Negative symptoms represent a significant unmet clinical need and the search for effective 
treatments has received renewed interest in recent years (Kirkpatrick et al., 2006). However, 
the mechanisms that underpin negative symptoms remain poorly understood. Negative 
symptoms can be subject to significant fluctuations over time, particularly in the early course 
of psychosis (Edwards et al., 1999; Ventura et al., 2004). Individuals vary in the stability of 
their negative symptoms (Kelley et al., 2008) and those with persistently elevated negative 
symptoms are at highest risk of poor outcome (Husted et al., 1992; Mäkinen et al., 2008). 
Increased understanding of variation in negative symptom course might help illuminate the 
mechanisms which underlie negative symptoms.  
 
The prevalence of persistent negative symptoms in first episode psychosis (FEP) remains 
unclear due to the use of inconsistent criteria for persistence. Moreover, grouping individuals 
into those with persistent negative symptoms and those without might mask the true 
complexity of individual variation in negative symptom course. Chen et al. (2013) found that 
variation in negative symptom course in a cohort of schizophrenia patients was best modelled 
by four distinct trajectory classes, characterised by differing levels of negative symptoms at 
baseline and a distinctive pattern of longitudinal change. It is not yet known whether multiple 
negative symptoms trajectories are similarly evident in FEP. This study examines negative 
symptom trajectories in a large FEP sample using latent class growth analysis (LCGA), a 
data-driven approach to identifying patterns of longitudinal change within a heterogeneous 
population. Predictors of the identified trajectories are then investigated. 
 
This study also explores the relationship between negative symptom course and social 
recovery. Although the association between negative symptoms during FEP and poor 
functional outcomes is well established (Evensen et al., 2012; Galderisi et al., 2013), the 
relationship between the trajectory of an individual’s negative symptoms and concurrent 
change in their functioning has yet to be investigated. Understanding the relationship between 
negative symptom course and contemporaneous changes in functioning might inform the 
development of targeted interventions to improve functional outcomes following FEP.   
 
2. Method 
 
2.1. Participants 
 The sample comprises participants in the National EDEN study: a national evaluation of the 
impact and cost-effectiveness of Early Intervention in Psychosis (EIP) services in the UK 
(Birchwood et al., 2014). All individuals accepted into EIP services in Birmingham, Bristol, 
Cambridge, Cornwall, Lancashire and Norfolk between August 2005 and April 2009 were 
invited to take part. The Policy Implementation Guide (Department of Health, 2001) provides 
details of the acceptance criteria for these services and the care they offer. In total, 1027 
individuals consented to take part: 80% were followed up at 6 months and 77% at 12 months. 
National EDEN participants assessed with the Positive and Negative Syndrome Scale 
(PANSS) at one time point or more (n = 1006) are included in the current study (see Table 1 
for sample characteristics and descriptive statistics). 
 
[Insert Table 1] 
 
2.2. Measures 
 
2.2.1. Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987) 
 
Participants were assessed using the PANSS following acceptance into EIP (baseline) and 6 
and 12 months later. The PANSS is a 30-item instrument designed to measure the severity of 
symptoms associated with schizophrenia. Symptom severity over the previous seven days is 
assessed by a trained rater following a semi-structured interview with the participant. Each 
symptom is rated on a 7-point scale from 1 (absent) to 7 (extreme).   
 
2.2.2. Time Use Survey (TUS; Fowler et al., 2009; Short, 2003) 
 
Time spent in ‘structured activity’ at baseline, 6 and 12 months, as measured by the Time Use 
Survey (TUS), was used as an index of social recovery. The TUS is a semi-structured 
interview designed to assess time spent participating in structured activity on average over 
the previous month. Structured activity is defined as time spent in paid employment, 
voluntary work, education, childcare, housework, sport and structured leisure activities. The 
number of hours per week spent engaged in structured activity on average over the previous 
month was the measure of functioning used to model social recovery trajectories. Social and 
occupational functioning have been deemed among the most important markers of recovery 
by experts by both professional (Kane et al., 2003) and lived experience (Pitt et al., 2007). 
Unlike many measures of functioning employed in psychosis research, the TUS has limited 
conceptual overlap with negative symptoms, reducing the risk of confounding.  
 
2.2.3. Other Measures Administered at Baseline 
 
Variables hypothesised to be associated with negative symptom course were measured at 
baseline. Self-reported social and academic adjustment in childhood (up to 11 years) and 
early adolescence (11 – 15 years) was assessed using the Premorbid Adjustment Scale (PAS; 
Cannon-Spoor et al., 1982). Duration of untreated psychosis was assessed retrospectively 
using the method described by Larsen et al. (1996). DUP was defined as the interval between 
onset of frank psychosis and commencement of criterion antipsychotic treatment, ascertained 
using participant report and examination of clinical notes. Continuous data were 
dichotomised to create a binary DUP variable (long DUP ≥ 9 months) due to the non-linear 
relationship between DUP and negative symptoms (Boonstra et al., 2012). The Calgary 
Depression Scale (CDSS; Addington et al., 1994) was used to measure depression and the 
Drug Check (Kavanagh et al., 1999) to assess illicit substance use. Family history of non-
affective psychosis was ascertained through participant report and diagnoses at baseline 
obtained from clinical notes.     
  
2.3. Analysis Plan 
 
Since it is now accepted that the factor structure of the PANSS is not well represented by the 
three original subscales (Kay et al., 2000; White et al., 1997), the PANSS items used to 
measure negative symptoms in this study were determined using Exploratory Structural 
Equation Modelling (ESEM; Asparouhov and Muthén, 2009). Whilst much work has been 
carried out to determine the factor structure of the PANSS in schizophrenia samples, fewer 
studies have examined its factor structure in FEP samples.ESEM is a factor analytic 
technique which both allows items to load on multiple factors and provides model fit indices, 
enabling adequate model fit to be verified. This approach was chosen since it has been argued 
that free estimation of cross-loadings is necessary to adequately reflect clinical reality and 
thus obtain satisfactory model fit (van der Gaag et al., 2006; van den Oord et al., 2006). 
ESEM with geomin rotation was conducted and the adequacy of model fit accessed using 
three indices. A five-factor model was specified based on the results of exploratory factor 
analysis.   
 
The study used latent class growth analysis (LCGA; Nagin, 2005) to identify distinct 
trajectories of change in negative symptom severity. LCGA is a technique used to identify 
homogenous sub-groups (latent classes) of individuals with distinct patterns of change over 
time (Andruff et al., 2009). Missing data were estimated using full information maximum 
likelihood under the assumption that data were missing at random. Models with increasing 
numbers of latent classes were fitted to the data and the best model selected according to a 
number of considerations including fit indices, entropy (a measure of the distinctness of 
classes), accuracy of posterior classifications (probability that participants were assigned to 
the correct latent class by the model), parsimony and interpretability (Jung and Wickrama, 
2008).  
 
Multinomial regression, with latent class according to the selected LCGA model as the 
dependent variable, was used to examine predictors of negative symptom course. There were 
twelve candidate exploratory variables: age at psychosis onset; gender; ethnicity; family 
history of non-affective psychosis; schizophrenia diagnosis; duration of untreated psychosis; 
premorbid social adjustment in childhood; premorbid social adjustment in adolescence; 
premorbid academic adjustment in childhood; premorbid academic adjustment in 
adolescence; baseline depression; and history of substance use.  Only variables that differed 
significantly between latent classes (according to Pearson’s Chi-Squared tests and one-way 
ANOVAs with Bonferroni correction) were entered into the multinomial regression model. 
An additional, post-hoc one-way ANOVA was conducted to explore whether members of the 
identified trajectory classes differed with respect to the severity of expressive deficit versus 
withdrawal symptoms (as identified through exploratory factor analysis) at baseline. 
 
Trajectories of social recovery were identified by using LCGA to model hours per week in 
structured activity as measure by the TUS, as described by Hodgekins et al. (2015b). The 
social recovery trajectory classes of each member of the identified negative symptom 
trajectory classes were determined by matching the participants in the current study with 
those included in Hodgekins et al.’s analysis using their identifier code. A matrix of negative 
symptom versus social recovery trajectories was constructed and individuals assigned to cells 
of the matrix according to their trajectory permutation. The independence of the trajectories 
was tested statistically using Pearson’s Chi-Squared test and adjusted standardised residuals 
of the test examined to interpret the results.   
 
Analyses were conducted using SPSS for Windows, Version 22 (IBM Corp., 2013) and 
Mplus for Windows, Version 7.1 (Muthén & Muthén, 1998-2012).  
 
3. Results 
 
3.1. Exploratory Structural Equation Modelling  
 
A five-factor model which fit the data adequately (RMSEA = 0.054; CFI = 0.914; TLI = 
0.874) resulted in a negative symptoms factor including the items ‘Blunted affect’, ‘Lack of 
spontaneity’, ‘Emotional withdrawal’, ‘Passive social withdrawal’, ‘Poor rapport’, ‘Motor 
retardation’ and ‘Active social avoidance’. The mean rating of these items was used to 
measure negative symptom severity. The identified factor structure was similar to that found 
in van der Gaag et al.’s (2006) study employing similar methods. Mirroring the findings of 
van de Gaag et al., ‘Active social avoidance’ was found to load on both the negative 
symptoms and affective symptoms factors.    
  
3.2.Negative Symptom Trajectories 
 
LCGA models with increasing numbers of latent classes were fitted to the data. Fit indices, 
entropy, accuracy of posterior classifications, and the size of each class were compared 
(Table 2) and the four class model selected. The four-class model (Figure 1) fit the data 
significantly better than the models with one, two or three latent classes according to all fit 
indices. Further, each of the four latent classes represented a distinct trajectory with 
theoretical relevance. Mean posterior probabilities were adequate (> 0.70), indicating high 
probability of classification to the correct latent class and no latent class was made up of less 
than 5% of the sample. Although the majority of fit indices suggested that the more latent 
classes included the better model fit, models with five or more latent classes were rejected for 
reasons of parsimony and interpretability. Models with five or more latent classes included 
classes comprising a very small proportion of the sample (less than 5%) and these additional 
trajectories were not sufficiently unique and distinct to add interpretive value.   
 
[Insert Table 2] 
[Insert Figure 1] 
 
3.3.Characteristics of Latent Classes 
 
The class size, unstandardised mean intercept, unstandardised mean gradient, the significance 
of this gradient (and corresponding p-value) for each trajectory class is presented in Table 3. 
 
[Insert Table 3] 
 
3.4. Predictors of Negative Symptom Course 
 
The four negative symptom trajectory classes were compared on demographic and baseline 
variables.  Descriptive statistics for each class are presented in Table 4.   
 
[Insert Table 4] 
 
Class differences were found in gender (χ2 (3) = 9.253, p = 0.026), baseline clinical diagnosis 
(Fisher’s Exact Test, p = 0.019), family history of non-affective psychosis (Fisher’s Exact 
Test, p = 0.001), premorbid social adjustment in childhood (F (3, 904) = 5.116, p = 0.002) 
and early adolescence (F (3, 864) = 7.240, p = <0.001), premorbid academic adjustment in 
childhood (F (3, 904) = 7.270, p = <0.001) and early adolescence (F (3, 899) = 10.236, p = 
<0.001), and baseline depression (F(3, 943) = 11.285, p = <0.001). These variables were 
entered into a multinomial regression with negative symptom trajectory class as the 
dependent variable. The Minimal Decreasing trajectory class served as the reference 
category.  
 
Compared to individuals in the Minimal Decreasing class, those in the High Stable class were 
more likely to be male (Β = -1.04, p = 0.03) and more likely to have a family history of non-
affective psychosis (Β = -1.18, p = 0.01). Compared to the Minimal Decreasing class, those 
in the High Decreasing class were more likely have a family history of non-affective 
psychosis (Β = -0.68, p = 0.046) and had higher levels of depression (Β = 0.09, p = <0.001). 
Members of the High Decreasing class also had better premorbid social adjustment during 
childhood than the Minimal Decreasing Group (Β = -2.21, p = 0.004) but poorer premorbid 
social adjustment in adolescence (Β = 2.11, p = 0.003). Full results of the multinomial 
regression are available as supplementary material.  
 
3.5. Relationships between Negative Symptom Trajectory and Social Recovery  
 
Three functioning trajectories were identified by Hodgekins et al.: (1) low levels of 
functioning sustained over the course of the study (‘Low Stable’); (2) moderate functioning 
which increased over the course of the study (‘Moderate Increasing’); and (3) initially high 
functioning which decreased slightly but remained high (‘High Decreasing’). The trajectories 
are depicted graphically in Hodgekins et al. (2015b; figure 1). Both the Moderate Increasing 
and High Decreasing classes, but not the Low Stable class, were engaging in levels of 
structured activity within the non-clinical range by 12 months and were therefore deemed to 
have made a good social recovery (Hodgekins et al., 2015b). Of the participants in the current 
study, 759 were also included in Hodgekins et al.’s analysis. These participants were assigned 
to cells of a matrix according to their permutation of negative symptom versus functioning 
trajectory (Table 5). 
 
[Insert Table 5] 
 
Negative symptom trajectories and functioning trajectories were not independent of one 
another (χ2 = 57.06, p = <0.001). Those in the High Stable, Mild Stable and High Decreasing 
negative symptom classes were over-represented in the Low Stable functioning class, 
indicating that those who followed a trajectory characterised by elevated negative symptoms 
at baseline, regardless of whether those negative symptoms decreased, were less likely to 
recover socially within 12 months. The Minimal Decreasing negative symptoms class were 
more likely to make a good social recovery within 12 months than members of other classes; 
nonetheless, the majority (56.9%) fell into the Stable Low functioning class. The proportion 
of each negative symptom trajectory class that made a good social recovery within the study 
period is presented graphically in Figure 2. 
 
[Insert Figure 2] 
   
4. Discussion 
 
4.1. General Discussion 
 
This study identified four distinct negative symptom trajectories in a large sample of 
individuals receiving treatment for FEP. Only a small proportion of the sample (5.4%) had 
persistently high levels of negative symptoms. A further 13.5% of the sample presented with 
consistently elevated negative symptoms of lesser severity. The mean intercept of both these 
trajectories was sufficiently high to indicate multiple clinically significant negative 
symptoms. Membership of the class with the highest levels of persistent negative symptoms 
was predicted by male gender and family history of non-affective psychosis. In line with 
previous research linking persistent negative symptoms and poor outcome, those with stably 
elevated negative symptoms were over-represented among those with poor social recovery.   
 
A trajectory of initially high but decreasing negative symptoms was followed by 17.1% of the 
sample. This supports a suggestion in the literature that initially elevated negative symptoms 
often decrease over time (Savill et al., 2015). Those with remitting negative symptoms were 
distinguished from those with consistently minimal negative symptoms by poorer premorbid 
social adjustment during adolescence despite better social adjustment during childhood. They 
were also more likely to have a family history of non-affective psychosis and had higher 
baseline depression. Despite the remission of their negative symptoms, this trajectory class 
were less likely to make a good social recovery than those with minimal negative symptoms 
at baseline. One possible explanation is that functioning disrupted by negative symptoms 
takes time to return to optimal levels following remission of those symptoms, resulting in 
delayed improvement in functioning relative to negative symptoms. Alternatively, given their 
poor premorbid adolescent functioning, it might be that the poor social recovery of this group 
is a legacy of low baseline functioning.   
 
Two subdomains of negative symptoms – expressive deficits and withdrawal 
(avolition/asociality) – have now been established (Liemburg et al., 2013). Therefore, a 
question arose whether the relative prominence of the two subdomains differed between 
trajectory classes. However a post-hoc one-way ANOVA revealed no significant differences 
between trajectory classes in the proportion of expressive deficit versus withdrawal 
symptoms at baseline (F = 2.22, p = 0.085), suggesting negative symptom trajectories were 
not associated with the type of negative symptoms present at baseline.    
      
The majority of the sample (63.9%) presented with consistently minimal negative symptoms. 
These participants were more likely to recover socially within 12 months than members of 
other classes. Nonetheless, more than half of this group did not make a good social recovery; 
whilst negative symptoms might be an important barrier to social recovery in some 
individuals, they are by no means necessary for poor social recovery.     
   
  
4.2. Clinical Implications 
 
The results of this study indicate that a substantial proportion of those with elevated negative 
symptoms at baseline will achieve remission of these symptoms within 12 months. However, 
even when negative symptoms remit, they are associated with poor social recovery. As such, 
those who present with elevated negative symptoms on entry to EIP services might benefit 
from close monitoring of their functioning and the provision of targeted interventions. Given 
that those with initially high but decreasing negative symptoms were often functioning poorly 
prior to psychosis, it is perhaps not surprising that they struggle to recover socially after its 
onset. Further research focusing on emerging negative symptoms and social disability during 
the prodromal phase would be helpful in understanding how these difficulties develop. It 
might be that intervention at this early stage – after the onset of non-specific negative 
symptoms and early signs of social disability but before the emergence of positive symptoms 
– is warranted (Fowler et al., 2010). Additionally, it might be that it is beneficial to engage 
the children of parents with psychosis in interventions designed to prevent early social 
disability.          
 
4.3. Limitations  
 
Although the PANSS is one of the most widely used measures of negative symptoms 
severity, it has significant limitations, both in its item content and reliance on behavioural 
observations for the assessment of experiential deficits (Blanchard et al., 2011). Measures 
developed since data collection for this study began (e.g. the Clinical Assessment Interview 
for Negative Symptoms (CAINS; Kring et al., 2013)) have sought to address these 
limitations; it would be interesting to compare the results of the current study with those of 
similar future studies that utilise these recently developed negative symptom measures. 
Similarly, whilst the TUS provides a valuable index of social recovery, it is limited in that it 
measures only quantity of engagement in activity, not quality of engagement or the personal 
meaning attributed to it. Considering personal recovery – a concept encompassing 
connectedness, hope, identity, meaning, and empowerment (Leamy et al., 2011) – in addition 
to functioning in future research could help minimise this limitation. 
 
Complete PANSS data at all three time points were only available for 63.4% of participants. 
As previously mentioned, missing data were estimated using full information maximum 
likelihood under the assumption that data were missing at random (MAR). However, there 
was evidence that those with lower levels of negative symptoms at baseline were more likely 
to have missing data: as such, the MAR assumption is not supported. It is arguably preferable 
for a study of negative symptoms to have higher attrition of participants with lower levels of 
baseline negative symptoms than vice versa. Nonetheless, since accepting the unsupported 
assumption that data are MAR introduces bias, the results of the study are in need of 
replication. 
 
Since participants were assessed at only three time points, the model forms that could be 
fitted to the data were limited. Further, the follow-up period of the current study was 
relatively short. Whilst the first 12 months of treatment are an important period for research 
given EIP services’ focus on providing intensive support soon after psychosis onset, it is 
possible that further trajectories would emerge if participants were followed over a longer 
period. A longer term follow-up incorporating more frequent assessment would provide a 
more nuanced picture of variation in negative symptom course. Since pharmacological 
treatment and other interventions could be important factors influencing negative symptom 
trajectories, the impact of treatment variables (including service engagement) on negative 
symptom trajectories should be explored in future research.       
 
4.4. Conclusions 
 
Distinct negative symptom trajectories can be identified within a FEP cohort. Persistent 
negative symptoms are observed in only a small proportion; many of those with high levels 
of negative symptoms at baseline will attain remission of these symptoms within 12 months. 
However where elevated negative symptoms are present at baseline, whether or not they 
remit, they are associated with poor social recovery. Further, even those with consistently low 
levels of negative symptoms mostly do not make a good social recovery following 12 months 
of EIP.   
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Tables: 
 
Table 1.  Sample characteristics and descriptive statistics 
 
 
Percentage Mean (SD) 
 
Median (Q1, Q3) 
 
 
Age at Onset  
 
Male Gender  
     
Ethnicity 
     White British 
     Asian 
     Black  
     Mixed 
     Other 
 
Family History of Non-Affective  
Psychosis  
 
Initial Clinical Diagnosis  
     Unspecified Psychosis 
     Schizophrenia 
     Bipolar 
     Drug Induced Psychosis 
     Paranoid Psychosis       
     Schizoaffective Disorder 
 
Antipsychotic Use at Baseline 
     Typical 
     Atypical 
     Both Typical and Atypical  
     No Antipsychotic 
      
Antipsychotic Use at 12 Months 
     Typical 
     Atypical 
     Both Typical and Atypical  
     No Antipsychotic 
 
Baseline PANSS  
     Positive Subscale 
     Negative Subscale 
     General Subscale 
     Negative Factor Item Average 
 
 
 
- 
 
69.1 
 
 
70.3 
15.5 
6.8 
4.2 
3.3 
 
8.9 
 
 
 
72.0 
10.6 
5.2 
6.7 
3.7 
1.7 
 
 
1.6 
78.7 
7.9 
12.7 
 
 
2.2 
76.5 
2.3 
18.9 
 
 
- 
- 
- 
- 
 
 
 
20.07 (7.78) 
 
- 
 
 
- 
- 
- 
- 
- 
 
- 
 
 
 
- 
- 
- 
- 
- 
- 
 
 
- 
- 
- 
- 
 
 
- 
- 
- 
- 
 
 
15.28 (6.03) 
14.80 (6.52) 
32.85 (9.95) 
2.16 (1.00) 
 
 
 
20 (18, 24) 
 
- 
- 
 
- 
- 
- 
- 
- 
 
- 
 
 
 
- 
- 
- 
- 
- 
- 
 
 
- 
- 
- 
- 
 
 
- 
- 
- 
- 
 
 
15 (10, 19) 
13 (9, 19) 
32 (25, 39) 
1.86 (1.29, 2.86) 
 
 
 PAS Social  
     Childhood 
     Adolescence 
 
PAS Academic 
     Childhood 
     Adolescence 
 
Baseline Calgary Depression 
 
 
 
- 
- 
 
 
- 
- 
 
- 
 
 
 
0.20 (0.21) 
0.23 (0.19) 
 
 
0.26 (0.21) 
0.36 (0.24) 
 
6.30 (5.38) 
 
 
0.17 (0, 0.33) 
0.17 (0.06, 0.33) 
 
 
0.25 (0.08, 0.42) 
0.33 (0.17, 0.50) 
 
5 (2, 10) 
Note. PANSS = Positive and Negative Syndrome Scale; PAS = Premorbid Adjustment Scale  
 
Table 2. Comparison of LCGA models with two to six latent classes 
 2 3 4 5 6 
AIC 5893.21 5740.96 5639.24 5564.28 5464.70 
BIC 5932.52 5795.01 5708.03 5647.81 5562.98 
BLRT 0.00 0.00 0.00 0.00 0.00 
LMR-LRT 0.00 0.06 0.03 0.13 0.06 
Entropy 0.83 0.81 0.79 0.79 0.79 
Classification 
Probabilities 
0.96, 0.90 0.84, 0.94, 
0.89 
0.84, 0.92, 
0.91, 0.79 
0.89, 0.77, 0.91, 
0.83, 0.80 
0.83, 0.76, 0.91, 
0.84, 0.88, 0.87 
Class Size 
(%) 
81, 19 21, 74, 5  14, 64, 5, 17 3, 17, 64, 11, 5 15, 14, 3, 7, 57, 
3 
Note. AIC = Akaike’s Information Criterion, BIC = Bayesian Information Criterion, BLRT = 
Bootstrap Likelihood Ratio Test, LMR-LRT = Lo–Mendell–Rubin Likelihood Ratio Test. 
Lower AIC and BIC values indicate superior fit. A significant BLRT or LMR-LRT value is 
indicative of the model being a better fit than the model with one fewer latent classes. 
Classification Probabilities = mean posterior probabilities for each class, Class Size = 
proportion of the sample making up the membership of each class.  
 
Table 3. Characteristics of latent classes 
Name Class size Unstandardised 
mean intercept 
Unstandardised 
mean gradient 
Significance 
of gradient 
Minimal Decreasing 
 
n = 674 
(63.9%) 
1.62 -0.17  Sig.  
(p = <0.001) 
Mild Stable 
 
n = 108 
(13.5%) 
2.19 0.24  Non sig. 
(p = 0.08) 
High Decreasing 
 
n = 174 
(17.1%) 
3.35 -0.89  Sig. 
(p = <0.001) 
High Stable 
 
n = 50  
(5.4%) 
 
3.58 0.05  Non sig. 
(p = 0.70) 
 
Table 4. Descriptive statistics (mean (SD) unless otherwise indicated) by negative symptom 
trajectory class.  
 Minimal 
Decreasing 
(n = 674) 
Mild Stable 
(n = 108) 
High 
Decreasing 
(n = 174) 
High Stable 
(n = 50) 
Age at Onset 
 
19.99 (8.45) 20.65 (5.27) 20.48 (6.54) 18.46 (6.78) 
Male Gender 
 
66.9% 77.8% 68.4% 82.0% 
White British Ethnicity 
 
70.9% 68.5% 72.4% 58.0% 
Family History 
 
6.9% 9.4% 11.5% 25.5% 
Schizophrenia 
Diagnosis 
 
9.8% 10.8% 9.6% 23.4% 
DUP ≥ 9 months 
 
27.8% 31.8% 28.3% 26.0% 
PAS Social - Childhood 
PAS Social - Adolescence 
          
0.19 (0.20) 
0.21 (0.18) 
 
0.25 (0.25) 
0.26 (0.23) 
 
0.17 (0.19) 
0.26 (0.21) 
 
0.27 (0.21) 
0.31 (0.17) 
 
PAS Academic - Childhood 
PAS Academic - Adolescence 
         
0.24 (0.21) 
0.33 (0.24) 
 
0.34 (0.21) 
0.45 (0.24) 
 
0.26 (0.19) 
0.41 (0.25) 
 
0.31 (0.21) 
0.41 (0.21) 
 
Calgary Depression 
 
5.61 (5.03) 
 
7.36 (5.62) 8.04 (5.66) 6.86 (6.60) 
 Substance Use 
 
66.3% 63.2% 68.5% 55.1% 
Note. Family History = Family History of Non-Affective Psychosis; DUP = Duration of 
Untreated Psychosis; PAS = Premorbid Adjustment Scale. 
 
 
 
 
 
 
 
 
 
Table 5. Matrix of intersections between negative symptom trajectory classes and social 
recovery trajectory classes.   
Note. The text in each cell refers to whether the class is over- or under-represented according 
to the adjusted standardised residual of the relevant Chi-Squared test.   
 
 
 
 
 
 
 
 
 
  
Figures: 
 
Fig. 1. LCGA with four latent classes: average negative symptom score estimated means  
 
 
 
Fig. 2. Proportion of each negative symptoms trajectory class that followed a social recovery 
trajectory characterised by non-clinical levels of structured activity by 12 months (‘Good 
Social Recovery’) versus those with stably low levels of structured activity (‘Poor Social 
Recovery’).  
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Proposed Supplementary Material: 
 
Supplementary Table. Results of multinomial regression investigating predictors of negative 
symptom trajectories. 
 B (SE) Odds Ratio  
(95% CI) 
 
P Value 
Stable Mild vs. Minimal Decreasing 
 
Female vs. Male 
 
Non-Schizophrenia Diagnosis vs. 
Schizophrenia Diagnosis 
 
No Family History vs. Family History 
 
PAS Social - Childhood 
PAS Social - Adolescence 
 
PAS Academic - Childhood 
PAS Academic - Adolescence 
 
Calgary Depression 
 
Stable High vs. Minimal Decreasing 
 
Female vs. Male 
 
Non-Schizophrenia Diagnosis vs. 
Schizophrenia Diagnosis 
 
No Family History vs. Family History 
 
PAS Social - Childhood 
PAS Social - Adolescence 
 
PAS Academic - Childhood 
PAS Academic - Adolescence 
 
Calgary Depression 
 
High Decreasing vs. Minimal 
Decreasing 
 
Female vs. Male 
 
 
 
-0.36 (0.30) 
 
0.04 (0.44) 
 
 
0.24 (0.48) 
 
-0.03 (0.84) 
0.63 (0.84) 
 
1.70 (0.90) 
0.52 (0.76) 
 
0.02 (0.02) 
 
 
 
-1.04 (0.48) 
 
-0.86 (0.44) 
 
 
-1.18 (0.44) 
 
-0.12 (1.18) 
2.17 (1.12) 
 
0.79 (1.25) 
-0.07 (1.08) 
 
0.05 (0.03) 
 
 
 
 
-0.06 (0.24) 
 
 
 
 
0.70 (0.39 – 1.25) 
 
1.04 (0.44 – 2.45) 
 
 
1.27 (0.50 – 3.21) 
 
0.98 (0.19 – 5.02) 
1.87 (0.36 – 9.65) 
 
5.50 (0.94 – 32.14) 
1.68 (0.38 – 7.48) 
 
1.02 (0.98 – 1.07) 
 
 
 
0.35 (0.14 – 0.90) 
 
0.42 (0.18 – 1.00) 
 
 
0.31 (0.13 – 0.72) 
 
0.89 (0.09 – 8.95) 
8.79 (0.99 – 78.11) 
 
2.21 (0.19 – 25.74) 
0.93 (0.11 – 7.66) 
 
1.06 (0.99 – 1.12) 
 
 
 
 
0.94 (0.60 – 1.50) 
 
 
 
 
0.23 
 
0.94 
 
 
0.62 
 
0.98 
0.46 
 
0.06 
0.49 
 
0.35 
 
 
 
0.03 
 
0.05 
 
 
0.01 
 
0.92 
0.051 
 
0.53 
0.95 
 
0.09 
 
 
 
 
0.81 
 
 
Non-Schizophrenia Diagnosis vs. 
Schizophrenia Diagnosis 
 
No Family History vs. Family History 
 
PAS Social - Childhood 
PAS Social - Adolescence 
 
PAS Academic - Childhood 
PAS Academic - Adolescence 
 
Calgary Depression 
 
0.37 (0.40) 
 
 
-0.68 (0.34) 
 
-2.21 (0.76) 
2.11 (0.71) 
 
-0.26 (0.77) 
1.01 (0.62) 
 
0.09 (0.02) 
1.45 (0.66 – 3.19) 
 
 
0.51 (0.30 – 0.99) 
 
0.11 (0.03 – 0.49) 
8.26 (2.07 – 33.01) 
 
0.77 (0.16 – 3.67) 
2.75 (0.82 – 9.29) 
 
1.09 (1.05 – 1.14) 
0.35 
 
 
0.046 
 
0.004 
0.003 
 
0.74 
0.10 
 
<0.001 
 
Note. Model: χ2 (24) = 92.50, p <0.001. Family History = family history of non-affective 
psychosis; PAS = Premorbid Adjustment Scale  
 
 
 
 
 
 
